🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
Primary Objectives: * VCDI cohort: * To determine the maximum tolerated...
Status
Completed
Location
Investigational Site Number : 250002
Start Date
2015-09-30
Trial ID
NCT02513186
Treatments Being Tested
Collection of retrospective additional data (survival, biological, disease ...
Status
Unknown
Location
Centre Hospitalier de la région d'Annecy
Start Date
2017-03-20
Trial ID
NCT03089411
The purpose of this study is to determine if bortezomib when added to conso...
Status
Completed
Location
Multiple Locations
Start Date
2012-01-13
Trial ID
NCT01539083
Treatments Being Tested
Paradoxical Vocal Fold Motion Disorder (PVFMD), otherwise known as vocal co...
Status
Completed
Location
BUMC
Start Date
2015-09
Trial ID
NCT02859974
Treatments Being Tested
This study will assess whether the combination of daratumumab and carfilzom...
Status
Recruiting
Location
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2023-10-20
Trial ID
NCT06140966
This phase 2 study will be conducted at 10 centers and enroll patients from...
Status
Unknown
Location
Jinling Hospital
Start Date
2013-08
Trial ID
NCT02086942
Treatments Being Tested
This study evaluates the potential synergic anti-myeloma activity of clarit...
Status
Terminated
Location
Department of Hematology, Aalborg University Hospital
Start Date
2015-01
Trial ID
NCT02573935
Treatments Being Tested
This phase II trial investigates whether patients greater than or equal to ...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2013-04-04
Trial ID
NCT01849783
Daratumumab for first line treatment of transplant-ineligible myeloma patie...
Status
Active Not Recruiting
Location
University of Cologne
Start Date
2021-06-01
Trial ID
NCT04656951
Treatments Being Tested